Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK

Primary Symbol: TAK

Healthcare

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

NYSE:TAK - Post by User

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs

Bullboard Posts

Post by TruthMachine2on Jun 30, 2011 11:11pm

216 Views

Post# 18787455

June 30 > insider activity - TAK

TSX Venture Exchange

Date	Symbol	Insider Buys Volume	Insider Sells Volume	Insider Buys Value $	Insider Sells Value $	Insider Buys Transaction	Insider Sells Transaction	Currency
Company Name : Taku Gold Corp.						Last Updated: June 30, 2011
06/30/2011	TAK	0	16,000	0.00	4,690.00	0	2	CAD

https://www.tmxmoney.com/HttpController?GetPage=SearchInsiderTrade&Language=en&Submit=Submit&QuerySymbol=tak&x=0&y=0

Taku Gold Corp. (TAK)						As of June 30th, 2011
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Unit Price
Jun 29/11	Jun 29/11	Dingsdale, Zachery	Direct Ownership	Common Shares	11 - Disposition carried out privately	-700,000	.100
Jun 29/11	Jun 27/11	Dingsdale, Zachery	Direct Ownership	Warrants	54 - Exercise of warrants	-700,000	.100
Jun 29/11	Jun 27/11	Dingsdale, Zachery	Direct Ownership	Common Shares	54 - Exercise of warrants	700,000	.100
Jun 29/11	Jun 24/11	Dingsdale, Zachery	Direct Ownership	Common Shares	10 - Disposition in the public market	-10,500	.330
Jun 24/11	Jun 23/11	Fekete, Mark	Indirect Ownership	Common Shares	10 - Disposition in the public market	-6,666
Jun 24/11	Jun 23/11	Fekete, Mark	Direct Ownership	Common Shares	10 - Disposition in the public market	-13,333
Jun 23/11	Jun 17/11	Smith, Stephen	Direct Ownership	Common Shares	10 - Disposition in the public market	-27,000	.325
Jun 20/11	Jun 17/11	Boga, Ickbal	Direct Ownership	Common Shares	11 - Disposition carried out privately	-200,000	.250
Jun 14/11	Jun 10/11	Boga, Ickbal	Direct Ownership	Common Shares	51 - Exercise of options	200,000	.250
Jun 14/11	Jun 10/11	Boga, Ickbal	Direct Ownership	Options	51 - Exercise of options	-200,000	.250